CannaPharmaRX finalizes multi-million dollar supply agreement with Cantek for Israeli cannabis market

CANNAPHARMARX, INC.

Agreement with Cantek, Israeli medical cannabis distributor, for minimum 1,000 kgs of product annually.
Initial shipment expected late Q1 2024; all necessary export and import permits secured.
Direct access to Israel's growing medical cannabis market, bolstered by recent supportive legislation.
CEO Dean Medwid states the agreement validates pre-sold product strategy for each planting cycle.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.